BWL
CABA icon

Bogart Wealth LLC’s Cabaletta Bio CABA Stock Holding History

Bogart Wealth LLC’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50
Closed -$114 – 1432
2024
Q4 		$114 Hold
50
– – ﹤0.01% 1322
2024
Q3 		$236 Hold
50
– – ﹤0.01% 1097
2024
Q2 		$374 Hold
50
– – ﹤0.01% 1063
2024
Q1 		$853 Hold
50
– – ﹤0.01% 982
2023
Q4 		$1.14K Hold
50
– – ﹤0.01% 952
2023
Q3 		$761 Hold
50
– – ﹤0.01% 981
2023
Q2 		$646 Hold
50
– – ﹤0.01% 973
2023
Q1 		$414 Buy
+50
New +$468 ﹤0.01% 1052

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bogart Wealth LLC's CABA Position: Q1 2025 in Review

Bogart Wealth LLC sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 50 shares — an estimated $114 sold.

Bogart Wealth LLC first reported a position in CABA in Q1 2023 and held it in 8 quarters. The position peaked at $1.14K in Q4 2023. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

  • Bogart Wealth LLC reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
  • Bogart Wealth LLC sold 50 Cabaletta Bio shares in Q1 2025, an estimated $114.
  • Bogart Wealth LLC first reported a position in Cabaletta Bio in Q1 2023 and held it in 8 quarters.
  • Bogart Wealth LLC's Cabaletta Bio position peaked at $1.14K in Q4 2023.
  • 92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on Bogart Wealth LLC's 13F filing for Q1 2025, filed 2 May 2025.